AboutContactTerms & Privacy
© 2026 Coverager
All Rights Reserved

Neurophth Therapeutics

A company looking to discover and develop gene therapies for patients suffering from blindness and other eye diseases globally.

Headquarters
Wuhan, Hubei, China
Founded
2016
Operating Status
Active
Ownership Type
Industry
Links
Number of funding rounds 5
Number of investors 21
Total funding amount $237.39M
Date Amount Stage Investors

Clients Only Feature

Client? Sign in to access this feature.
Not a client? Learn more about Coverager Research.